Annual Cash & Cash Equivalents
$484.60M$369.30M-43.25%
Summary
- Current Value
- As of today, WST annual cash & cash equivalents is $484.60M, down -43.25% on
- Historical Performance
- WST annual cash & cash equivalents is down -36.45% over the past 3 years, and up +10.36% over the past 5 years
- All-Time High Comparison
- WST annual cash & cash equivalents is currently -45.81% below its historical high of $894.30M set on
- 3-Year Low Comparison
- WST annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- WST annual cash & cash equivalents is higher than 88.79% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $484.60M | -43.3% | -36.5% | +10.4% | – | |
| Quarterly Cash & Cash Equivalents | $628.50M | +28.0% | -13.8% | +21.0% | +547.3% | |
| Price | $275.52 | -18.2% | +14.4% | -10.4% | +1251.3% | |
| Annual Current Assets | $1.54B | -20.6% | -11.7% | +45.3% | +287.2% | |
| Annual Total Liabilities | $961.10M | +1.3% | -1.8% | – | +38.9% | |
| Annual Working Capital | $987.70M | -21.9% | -14.0% | +37.7% | +336.8% | |
| Annual Net Income | $492.70M | -17.0% | -25.6% | +103.8% | +578.6% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $894.30M | N/A | -45.8% |
| 5Y | $894.30M | -45.8% | |
| All | $894.30M | -45.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $484.60M | at low | |
| 5Y | $484.60M | at low | |
| All | $1.60M | >+9999.0% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $484.60M | -43.2% | |
| $853.90M | -4.5% | |
| $894.30M | +17.3% | |
| $762.60M | +23.9% | |
| $615.50M | +40.2% |
| Year | Value | Change |
|---|---|---|
| $439.10M | +116.3% | |
| $203.00M | -26.1% | |
| $274.60M | +7.6% | |
| $255.30M | - |
FAQ
What is the current annual cash & cash equivalents of WST?
As of today, WST annual cash & cash equivalents is $484.60M
What is 1-year change in WST annual cash & cash equivalents?
WST annual cash & cash equivalents is down -43.25% year-over-year
What is 3-year change in WST annual cash & cash equivalents?
WST annual cash & cash equivalents is down -36.45% over the past 3 years
How far is WST annual cash & cash equivalents from its all-time high?
WST annual cash & cash equivalents is currently -45.81% below its historical high of $894.30M set on December 31, 2022
How does WST annual cash & cash equivalents rank versus sector peers?
WST annual cash & cash equivalents is higher than 88.79% of companies in Healthcare sector
When is WST next annual earnings release?
The next annual earnings release for WST is on
Quarterly Cash & Cash Equivalents
$628.50M$118.80M+23.31%
Summary
- Current Value
- As of today, WST quarterly cash & cash equivalents is $628.50M, up +23.31% on
- Historical Performance
- WST quarterly cash & cash equivalents is up +28.03% year-over-year, and down -13.79% over the past 3 years
- All-Time High Comparison
- WST quarterly cash & cash equivalents is currently -30.06% below its historical high of $898.60M set on
- 3-Year Low Comparison
- WST quarterly cash & cash equivalents is +55.49% above its 3-year low of $404.20M reached on
- Sector Comparison
- WST quarterly cash & cash equivalents is higher than 88.12% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $628.50M | +23.3% | +28.0% | -13.8% | +21.0% | |
| Annual Cash & Cash Equivalents | $484.60M | – | -43.3% | -36.5% | +10.4% | |
| Price | $275.52 | +4.5% | -18.2% | +14.4% | -10.4% | |
| Quarterly Current Assets | $1.82B | +8.5% | +17.6% | +5.2% | +47.2% | |
| Quarterly Total Liabilities | $1.05B | +3.0% | +14.2% | +24.6% | +22.0% | |
| Quarterly Working Capital | $1.19B | +10.4% | +14.9% | -7.0% | +50.3% | |
| Quarterly Net Income | $140.00M | +6.2% | +2.9% | +16.1% | +70.1% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $628.50M | at high | |
| 3Y | $898.60M | -30.1% | |
| 5Y | $898.60M | -30.1% | |
| All | $898.60M | -30.1% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $404.20M | +55.5% | |
| 3Y | $404.20M | +55.5% | |
| 5Y | $404.20M | +55.5% | |
| All | $300.00K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of WST?
As of today, WST quarterly cash & cash equivalents is $628.50M
What is WST quarterly cash & cash equivalents most recent change?
WST quarterly cash & cash equivalents was up +23.31% on September 30, 2025
What is 1-year change in WST quarterly cash & cash equivalents?
WST quarterly cash & cash equivalents is up +28.03% year-over-year
How far is WST quarterly cash & cash equivalents from its all-time high?
WST quarterly cash & cash equivalents is currently -30.06% below its historical high of $898.60M set on September 30, 2023
How does WST quarterly cash & cash equivalents rank versus sector peers?
WST quarterly cash & cash equivalents is higher than 88.12% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- WST Official Website www.westpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/105770/000010577025000093/0000105770-25-000093-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577025000013/0000105770-25-000013-index.htm
- WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
- WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst